$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921011156 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$251.0M	$256.1M
YoY Change	-2.01%	3.16%
Cost Of Revenue	$141.8M	$146.6M
YoY Change	-3.31%	3.72%
Gross Profit	$109.2M	$109.5M
YoY Change	-0.27%	2.42%
Gross Profit Margin	43.51%	42.75%
Selling, General & Admin	$10.06M	$10.33M
YoY Change	-2.6%	0.92%
% of Gross Profit	9.22%	9.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.16M	$10.44M
YoY Change	-2.65%	-0.75%
% of Gross Profit	9.31%	9.53%
Operating Expenses	$85.22M	$91.49M
YoY Change	-6.85%	1.44%
Operating Profit	$15.22M	$15.81M
YoY Change	-3.69%	0.13%
Interest Expense	$244.0K	$412.0K
YoY Change	-40.78%	-55.51%
% of Operating Profit	1.6%	2.61%
Other Income/Expense, Net	$6.260M	$8.146M
YoY Change	-23.15%	35.74%
Pretax Income	$28.54M	-$36.44M
YoY Change	-178.32%	-227.31%
Income Tax	$7.233M	-$9.625M
% Of Pretax Income	25.34%
Net Earnings	$21.27M	-$26.85M
YoY Change	-179.2%	-226.25%
Net Earnings / Revenue	8.47%	-10.48%
Basic Earnings Per Share	$1.39	-$1.76
Diluted Earnings Per Share	$1.38	-$1.76
COMMON SHARES
Basic Shares Outstanding	15.33M	15.29M
Diluted Shares Outstanding	15.39M	15.29M

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$463.6M	$86.18M
YoY Change	437.98%	66.75%
Cash & Equivalents	$134.1M	$69.49M
Short-Term Investments	$329.5M	$16.69M
Other Short-Term Assets	$34.56M	$35.03M
YoY Change	-1.34%	6.57%
Inventory	$8.117M	$7.904M
Prepaid Expenses
Receivables	$94.29M	$100.4M
Other Receivables	$8.804M	$1.785M
Total Short-Term Assets	$464.6M	$306.7M
YoY Change	51.5%	-6.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$514.5M	$540.6M
YoY Change	-4.83%	1.47%
Goodwill	$168.3M	$21.34M
YoY Change	688.6%	1.65%
Intangibles
YoY Change
Long-Term Investments	$35.48M	$38.77M
YoY Change	-8.49%	11.49%
Other Assets	$376.2M	$409.0M
YoY Change	-8.02%	-9.59%
Total Long-Term Assets	$890.7M	$949.6M
YoY Change	-6.21%	-3.61%
TOTAL ASSETS
Total Short-Term Assets	$464.6M	$306.7M
Total Long-Term Assets	$890.7M	$949.6M
Total Assets	$1.355B	$1.256B
YoY Change	7.88%	-4.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.11M	$18.28M
YoY Change	-11.83%	-5.4%
Accrued Expenses	$121.2M	$103.1M
YoY Change	17.61%	5.71%
Deferred Revenue	$51.25M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.489M	$50.00M
YoY Change	-91.02%
Total Short-Term Liabilities	$265.8M	$218.0M
YoY Change	21.96%	28.25%
LONG-TERM LIABILITIES
Long-Term Debt	$9.393M	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$29.97M	$14.59M
YoY Change	105.44%	-4.68%
Total Long-Term Liabilities	$29.97M	$14.59M
YoY Change	105.44%	-79.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$265.8M	$218.0M
Total Long-Term Liabilities	$29.97M	$14.59M
Total Liabilities	$545.1M	$513.0M
YoY Change	6.27%	-8.66%
SHAREHOLDERS EQUITY
Retained Earnings	$576.3M	$518.3M
YoY Change	11.2%	-2.22%
Common Stock	$154.0K	$153.0K
YoY Change	0.65%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$807.1M	$742.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.355B	$1.256B
YoY Change	7.88%	-4.27%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$21.27M	-$26.85M
YoY Change	-179.2%	-226.25%
Depreciation, Depletion And Amortization	$10.16M	$10.44M
YoY Change	-2.65%	-0.75%
Cash From Operating Activities	$12.59M	$7.754M
YoY Change	62.35%	-33.16%
INVESTING ACTIVITIES
Capital Expenditures	$4.327M	$6.628M
YoY Change	-34.72%	12.84%
Acquisitions
YoY Change
Other Investing Activities	-$1.525M	-$9.597M
YoY Change	-84.11%	-427.88%
Cash From Investing Activities	-$5.852M	-$16.23M
YoY Change	-63.93%	450.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$49.00K	-$347.0K
YoY Change	-85.88%	-218.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$9.148M	$31.64M
YoY Change	-128.91%	-456.52%
NET CHANGE
Cash From Operating Activities	$12.59M	$7.754M
Cash From Investing Activities	-$5.852M	-$16.23M
Cash From Financing Activities	-$9.148M	$31.64M
Net Change In Cash	-$2.411M	$23.17M
YoY Change	-110.41%	-10584.16%
FREE CASH FLOW
Cash From Operating Activities	$12.59M	$7.754M
Capital Expenditures	$4.327M	$6.628M
Free Cash Flow	$8.262M	$1.126M
YoY Change	633.75%	-80.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15393140
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15390140
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15390140
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15369745
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15369745
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	240319000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2021Q1	nhc	Number Of Independent Living Facilities NumberOfIndependentLivingFacilities	5	pure
CY2021Q1	nhc	Number Of Geriatric Psychiatric Hospitals NumberOfGeriatricPsychiatricHospitals	1	pure
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021Q1	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2177000	USD
CY2020Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2177000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51253000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2911000	USD
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2021Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	216855000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244095000	USD
CY2021Q1	nhc	Other Revenues OtherRevenues	11369000	USD
CY2020Q1	nhc	Other Revenues OtherRevenues	12029000	USD
CY2021Q1	nhc	Government Assistance Stimulus Income Cares Act GovernmentAssistanceStimulusIncomeCaresAct	22749000	USD
CY2020Q1	nhc	Government Assistance Stimulus Income Cares Act GovernmentAssistanceStimulusIncomeCaresAct	0	USD
CY2021Q1	us-gaap	Revenues Revenues	250973000	USD
CY2020Q1	us-gaap	Revenues Revenues	256124000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	145130000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	147469000	USD
CY2021Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	70153000	USD
CY2020Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	71668000	USD
CY2021Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10063000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10332000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10161000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10438000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	244000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	412000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	235751000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15222000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15805000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6260000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8146000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	7059000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	28541000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36441000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7233000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9625000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	21308000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	41000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	36000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	21267000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.76
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.38
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.76
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15327520
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15294777
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15390076
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15294777
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2021Q1	us-gaap	Profit Loss ProfitLoss	21308000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-2440000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-2545000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	2000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-518000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-535000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1922000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2012000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	41000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	36000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19345000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28864000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134107000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147093000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20257000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9673000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	135246000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	128590000	USD
CY2021Q1	us-gaap	Debt Securities Current DebtSecuritiesCurrent	49492000	USD
CY2020Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	47762000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Restricted EquitySecuritiesFvNiRestricted	5083000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni Restricted EquitySecuritiesFvNiRestricted	4680000	USD
CY2021Q1	nhc	Restricted Marketable Debt Securities Current RestrictedMarketableDebtSecuritiesCurrent	5724000	USD
CY2020Q4	nhc	Restricted Marketable Debt Securities Current RestrictedMarketableDebtSecuritiesCurrent	16601000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	94292000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89670000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	8117000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	8781000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3496000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2977000	USD
CY2021Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	8804000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	928000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	464618000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	456755000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1034747000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1030426000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	520263000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	510108000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	514484000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	520318000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1727000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1736000	USD
CY2021Q1	nhc	Restricted Marketable Debt Securities Noncurrent RestrictedMarketableDebtSecuritiesNoncurrent	133959000	USD
CY2020Q4	nhc	Restricted Marketable Debt Securities Noncurrent RestrictedMarketableDebtSecuritiesNoncurrent	125472000	USD
CY2021Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4661000	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4580000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	172764000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	179055000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	21341000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	21341000	USD
CY2021Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3962000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12093000	USD
CY2021Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	37796000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	40782000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	376210000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	385059000	USD
CY2021Q1	us-gaap	Assets Assets	1355312000	USD
CY2020Q4	us-gaap	Assets Assets	1362132000	USD
CY2021Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	16113000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	21112000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4489000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4423000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25759000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25451000	USD
CY2021Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	64406000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	86183000	USD
CY2021Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	15574000	USD
CY2020Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	16454000	USD
CY2021Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	31065000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	30953000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25674000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	21344000	USD
CY2021Q1	nhc	Provider Relief Funds ProviderReliefFunds	23510000	USD
CY2020Q4	nhc	Provider Relief Funds ProviderReliefFunds	16068000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51253000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51253000	USD
CY2021Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	8003000	USD
CY2020Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7987000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	265846000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	281228000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9393000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	10540000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	147005000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	153604000	USD
CY2021Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	70416000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	68584000	USD
CY2021Q1	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	7334000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	7462000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	15157000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14079000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29973000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28375000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	545124000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	563872000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	154000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	153000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	227487000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	226943000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	576288000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	563024000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3135000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5057000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	807064000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1596000	USD
CY2020Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	353000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15008000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	496000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	466000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4622000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6212000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-0	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2560000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-664000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	372000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	601000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1515000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4999000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1408000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21777000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21343000	USD
CY2021Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	-880000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	795177000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	3124000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	3083000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	810188000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	798260000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1355312000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1362132000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	21308000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10161000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10438000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2911000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2811000	USD
CY2021Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5897000	USD
CY2020Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2349000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	7059000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	2000	USD
CY2021Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	-0	USD
CY2020Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	1707000	USD
CY2021Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	1945000	USD
CY2020Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4623000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7442000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4331000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3365000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1598000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	402000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12589000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7754000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4327000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6628000	USD
CY2021Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	-0	USD
CY2020Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6648000	USD
CY2021Q1	nhc	Payments For Proceeds From Unconsolidated Investments PaymentsForProceedsFromUnconsolidatedInvestments	-0	USD
CY2020Q1	nhc	Payments For Proceeds From Unconsolidated Investments PaymentsForProceedsFromUnconsolidatedInvestments	125000	USD
CY2021Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	USD
CY2020Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	250000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	255000	USD
CY2020Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	376000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7866000	USD
CY2020Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6360000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	6086000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	3410000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5852000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16225000	USD
CY2021Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	40000000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1081000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1019000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7988000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7968000	USD
CY2021Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2020Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	281000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	327000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	400000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	278000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	53000	USD
CY2021Q1	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-128000	USD
CY2020Q1	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9148000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31641000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2411000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23170000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	158502000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61010000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	156091000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	84180000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134107000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69492000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	21984000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	14688000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	156091000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84180000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	779069000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2020Q1	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	281000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2012000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	466000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	400000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	53000	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7980000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	743355000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	798260000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	21308000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1922000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	496000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	327000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51253000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	278000	USD
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	8003000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	810188000	USD
CY2021Q1	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	75	pure
CY2021Q1	nhc	Number Of Beds NumberOfBeds	9463	pure
CY2021Q1	nhc	Number Of Assisted Living Facilities NumberOfAssistedLivingFacilities	24	pure
CY2021Q1	nhc	Number Of Homecare Programs NumberOfHomecarePrograms	35	pure
CY2021Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10	pure
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;"><i>Estimates and Assumptions</i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt; text-indent: 36pt;">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period, including but <em style="font: inherit;">not</em> limited to, the potential future effects of the novel coronavirus (“COVID-<em style="font: inherit;">19”</em>).</p>
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	919000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	830000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6268000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5672000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5369000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5498000	USD
CY2021Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	7334000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	7462000	USD
CY2021Q1	nhc	Proceeds From Medicare Accelerated And Advance Payment Program ProceedsFromMedicareAcceleratedAndAdvancePaymentProgram	51253000	USD
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;"><i>Prior Period Classification</i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt; text-indent: 36pt;">Certain amounts in prior periods have been reclassified to conform with current period presentation.</p>
CY2021Q1	nhc	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCaresAct	30191000	USD
CY2021Q1	nhc	Government Assistance Stimulus Income Cares Act GovernmentAssistanceStimulusIncomeCaresAct	22749000	USD
CY2021Q1	nhc	Provider Relief Funds ProviderReliefFunds	23510000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	216855000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244095000	USD
CY2021Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1	pure
CY2020Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1	pure
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51253000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51253000	USD
CY2021Q1	nhc	Proceeds From Government Assistance Medicare Accelerated And Advance Payment Program ProceedsFromGovernmentAssistanceMedicareAcceleratedAndAdvancePaymentProgram	0	USD
CY2021Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5647000	USD
CY2020Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5679000	USD
CY2021Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4324000	USD
CY2020Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4478000	USD
CY2021Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1264000	USD
CY2020Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1382000	USD
CY2021Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	134000	USD
CY2020Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	490000	USD
CY2021Q1	nhc	Other Revenues OtherRevenues	11369000	USD
CY2020Q1	nhc	Other Revenues OtherRevenues	12029000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	5506000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	5503000	USD
CY2021Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	141000	USD
CY2020Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	176000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5647000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5679000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2811000	USD
CY2021Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1962000	USD
CY2020Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	2022000	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1387000	USD
CY2020Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1606000	USD
CY2021Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	0	USD
CY2020Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	1707000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6260000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8146000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	35480000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10332000	USD
CY2020Q1	us-gaap	Revenues Revenues	256124000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	147469000	USD
CY2020Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	71668000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	216855000	USD
CY2021Q1	nhc	Other Revenues OtherRevenues	11369000	USD
CY2021Q1	nhc	Government Assistance Stimulus Income Cares Act GovernmentAssistanceStimulusIncomeCaresAct	22749000	USD
CY2021Q1	us-gaap	Revenues Revenues	250973000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	145130000	USD
CY2021Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	70153000	USD
CY2021Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10063000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10161000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	244000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	235751000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15222000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6260000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	7059000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	28541000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244095000	USD
CY2020Q1	nhc	Other Revenues OtherRevenues	12029000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10438000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	412000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	240319000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15805000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8146000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36441000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	5200000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	35224000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	5200000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	34855000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	4767000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	34554000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	34370000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34233000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	31400000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	15167000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	204636000	USD
CY2021Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1285000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	31872000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	13882000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	172764000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4489000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25759000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9393000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	147005000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15327520
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15294777
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	21267000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.76
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	62556
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15390076
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15294777
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	21267000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.38
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.76
CY2021Q1	nhc	Marketable Securities Availableforsale Amortized Cost MarketableSecuritiesAvailableforsaleAmortizedCost	220176000	USD
CY2021Q1	us-gaap	Marketable Securities MarketableSecurities	329504000	USD
CY2020Q4	nhc	Marketable Securities Availableforsale Amortized Cost MarketableSecuritiesAvailableforsaleAmortizedCost	218396000	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	323105000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0010	pure
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	49863000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	98320000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	101326000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	99143000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	103002000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	36282000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	36994000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	34326000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	50615000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	50855000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	49694000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	36685000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	0	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	274000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	285000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	185217000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	189175000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	183437000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	189835000	USD
CY2021Q1	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	105464000	USD
CY2020Q4	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	98445000	USD
CY2021Q1	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	94000	USD
CY2020Q4	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	134000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	7059000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4973000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6759000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1015000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	361000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	6086000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3410000	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	496000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	466000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.201	pure
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y2M12D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0315	pure
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2637000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0291	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0087	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4474	pure
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	115900
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	70.01
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	6000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	809529
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.24
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	104057
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	73.98
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	43630
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	63.37
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	866956
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	72.11
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10704
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	67.28
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	755760
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	72.36
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4541600	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	210686
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	68.35
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	767000	USD
CY2021Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	755760
CY2021Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	72.36
CY2021Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y3M18D
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.253	pure
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.264	pure
CY2021Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	101481000	USD
CY2020Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	99537000	USD

Files In Submission

Name	View Source	Status
0001437749-21-011156-index-headers.html	Edgar Link	pending
0001437749-21-011156-index.html	Edgar Link	pending
0001437749-21-011156.txt	Edgar Link	pending
0001437749-21-011156-xbrl.zip	Edgar Link	pending
ex_245141.htm	Edgar Link	pending
ex_245142.htm	Edgar Link	pending
ex_245143.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhc-20210331.xsd	Edgar Link	pending
nhc-20210331_cal.xml	Edgar Link	unprocessable
nhc-20210331_def.xml	Edgar Link	unprocessable
nhc-20210331_lab.xml	Edgar Link	unprocessable
nhc-20210331_pre.xml	Edgar Link	unprocessable
nhc20210331_10q.htm	Edgar Link	pending
nhc20210331_10qimg001.jpg	Edgar Link	pending
nhc20210331_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2021 Q1 Form 10-Q Financial Statement

#000143774921011156 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2021 Q1 Form 10-Q Financial Statement

#000143774921011156 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc